PAVmed Inc.
PAVM
$0.71
$0.034.41%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | 110.20% | 464.43% | 25.52% | 15.16% | 31.40% |
Total Depreciation and Amortization | -90.48% | -67.53% | -59.17% | -19.39% | -0.14% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -261.14% | -1,734.59% | -157.75% | -56.26% | -174.43% |
Change in Net Operating Assets | -49.39% | -137.53% | -174.03% | 121.45% | 6.84% |
Cash from Operations | 100.79% | 19.89% | 8.30% | 19.88% | 29.42% |
Capital Expenditure | 97.81% | 66.67% | 80.00% | -61.54% | 38.59% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 100.00% | -65.00% | -- | -- | -- |
Cash from Investing | 97.81% | -89,538.89% | 80.00% | -104.31% | 38.59% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | 100.00% | -- | -- | -- | -- |
Issuance of Common Stock | -10.08% | 268.83% | -67.49% | 14.75% | 364.56% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -100.00% | -100.00% | -- | 30.57% | 499,900.00% |
Cash from Financing | -93.76% | -19.32% | 1,808.37% | -23.58% | 6,510.00% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 106.20% | -129.98% | 99.69% | -38.16% | 60.28% |